Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

76.28 +0.74 (+0.98%)
Official Closing Price Updated: 4:10 PM EDT, Apr 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
18 19 Next >
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
From Edwards Lifesciences Corporation
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 2
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Nov. 27 through Dec. 1. 
Via Talk Markets
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
Analyst Expectations for Edwards Lifesciences's Future
Via Benzinga
$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today
Via Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Zscaler Posts Q1 Results, Joins argenx, Cool Company And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded mixed this morning, with the Dow Jones futures gaining around 15 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Could Ozempic Harm These 3 Medical Device Stocks?
The drug is on track to cause massive competitive shifts in the healthcare sector. 
Via The Motley Fool
Jim Cramer Says This Tech Stock Up More Than 60% In 2023 Is An 'Expensive Stock, But It Is A Good One'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Trade Desk, Inc. 
Via Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
Earnings Scheduled For October 25, 2023
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion. 
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
P/E Ratio Insights for Edwards Lifesciences
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
Why Edwards Lifesciences Stock Plummeted Today
Investors trade on potential rather than trailing results, and they found the company's top-line guidance wanting. 
Via The Motley Fool
US Stocks Poised For Mixed Start Ahead Of Meta Earnings: Analyst Sees Corporate Profits Providing 'Fundamental Ballast' To Market
With numerous headwinds in play, analysts have stressed the importance of robust corporate profit growth to sustain valuations. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
Via Benzinga
Expert Ratings for Edwards Lifesciences
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $15,000 Today
Via Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises. 
Via Benzinga
Topics Stocks
Exposures US Equities
Edwards Lifesciences Faces European Scrutiny Over Patent Policies, Copycat Devices
U.S. medical devices manufacturer Edwards Lifesciences Corp (NYSE: EW) is reportedly under the scrutiny of EU antitrust regulators for its patent practices and policies aimed at thwarting copycat... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
Via Benzinga
Edwards Lifesciences Commits to Fair Competition Amid Regulatory Scrutiny, Analyst Upgrades Stock
The European Commission conducted a surprise inspection at Edwards Lifesciences Corp's (NYSE: EW) facility within a European Union member state due to suspicions of potential market power abuse,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2023
Via Benzinga
Cramer Says 'I Have No Idea What's Happening' To A Once-Favored Stock Down 35% YTD
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Edwards Lifesciences Corporation (NYSE: EW) used to be "one of the greatest stocks of our time and, it’s now 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.